Exercise Emerges as Powerful, Side-Effect-Free Treatment for Parkinson’s Disease
An estimated 10 million people worldwide live with Parkinson’s disease, a figure projected to rise by 40% or more by 2040. Despite growing prevalence and a deeper understanding of the disease’s impact, current care guidelines in some regions are failing to prioritize a readily available and increasingly vital treatment: intensive exercise.
Parkinson’s disease, the second most common neurodegenerative brain disorder after Alzheimer’s, affects motor skills, balance, and speech, often manifesting as tremors, stiffness, and slowed movement. While the underlying cause remains unknown, the impact on patients’ lives is undeniable, as tragically exemplified by the recent passing of Ozzy Osbourne, a high-profile individual who lived with the condition.
A growing concern centers on the National Board of Health and Welfare’s guidelines for Parkinson’s and multiple sclerosis care, last revised in 2022. Experts worry these guidelines do not adequately emphasize the crucial role of intensive exercise in managing the disease. This oversight risks lagging behind both cutting-edge research and the proactive efforts of patients themselves. A recent European study revealed a stark disparity in access to physiotherapy, with Sweden and Iceland offering a mere ten hours of socially funded training per year – significantly less than Denmark’s 104 hours and Germany’s 120-240 hours.
The dismissal of exercise as a viable treatment has a long and damaging history. As far back as 1899, Sir William Gowers’ influential “Manual of diseases of the nervous system” promoted the idea that stillness was best for sufferers. This outdated belief, perpetuated for over a century, tragically delayed the recognition of exercise as a vital therapeutic intervention.
The turning point arrived in 2003 with a serendipitous observation. Neuroscientist Dr. Jay Alberts noticed a remarkable improvement in the symptoms of Parkinson’s patient Cathy Frazer after she participated in strenuous tandem bike rides. Her tremors subsided, and her handwriting, often compromised by the disease, became legible again. this breakthrough built upon earlier animal studies demonstrating the brain’s plasticity – its ability to change and adapt – and the positive influence of physical activity. Researchers discovered that intense exercise could not only alleviate symptoms but perhaps slow the disease’s progression.
This discovery spurred further innovation.In 2006, similar benefits were observed in a Parkinson’s patient who was a prosecutor, leading to the founding of Rock Steady Boxing around 2010 in the United States. The institution now boasts 800 affiliated clubs and gyms,serving over 50,000 individuals.
Inspired by this success, the narva boxing club in Sweden began offering similar training in 2015, sparking a movement that involved approximately 20 clubs before the pandemic. Currently, over 100 people regularly participate in these programs, reporting significant improvements in quality of life and symptom management, with funding support from Allmänna arvsfonden.
Unlike pharmacological interventions, exercise boasts a unique advantage: it has no negative side effects. On the contrary, it offers a multitude of benefits, including a reduced risk of cardiovascular disease, improved balance, increased strength, and an overall enhanced quality of life. As Parkinson’s is a neurological,not a muscular,disease,exercise – and the crucial social connection fostered by group training – can be effectively integrated into the existing Swedish sports infrastructure.
To realize this potential, a mandate for training as a supplement to care must be included in the annual regulation letter sent by the government to the National Sports Confederation, alongside its 2.1 billion kroner in funding. This would formally recognize the medical value of exercise and ensure long-term access for patients. The benefits of “exercise as medicine” extend far beyond Parkinson’s, encompassing a wide range of neurological and chronic conditions. Though, given the compelling evidence supporting its efficacy in Parkinson’s disease, it represents an ideal starting point for a broader, future-focused model.
It is time for Sweden to fully embrace scientific advancements and recognize intensive training as the powerful, side-effect-free medicine it truly is. This is about empowering Sweden’s Parkinson’s patients to live active, symptom-managed, and meaningful lives.
